New competitor to Wegovy shows promise in clinical trials
An experimental drug appears to outperform the trendy medications Wegovy and Ozempic for both weight loss and diabetes control, a pair of early clinical trials shows.
Jun 27, 2023
0
1
An experimental drug appears to outperform the trendy medications Wegovy and Ozempic for both weight loss and diabetes control, a pair of early clinical trials shows.
Jun 27, 2023
0
1
More than half of patients with diabetes and a history of metabolic surgery (51%) experienced remission of their diabetes even if they did not achieve significant weight loss after surgery, according to a new study presented ...
Jun 27, 2023
0
4
After drugmaker Novo Nordisk tweaked its diabetes drug Ozempic into Wegovy—a formulation expressly designed to help users shed pounds—sales of both drugs skyrocketed.
Jun 26, 2023
0
8
Closed-loop insulin delivery systems improve glucose control in children with type 1 diabetes without causing adverse effects, according to a study presented Saturday at ENDO 2023, the Endocrine Society's annual meeting in ...
Jun 17, 2023
0
3
Studies in a new doctoral thesis indicate that an AI-supported method is effective in the diagnosis of squamous cell carcinoma of the head and neck (SCCHN). In addition, machine learning (ML, a subfield of artificial intelligence) ...
Jun 12, 2023
0
26
Over 55 million people worldwide have dementia. This mind-robbing condition has a huge impact on society and the economy, so scientists are working hard to find ways to treat or prevent it. One of the avenues being explored ...
May 19, 2023
0
30
Researchers from Sanford Burnham Prebys and the Chinese University of Hong Kong have developed a computational approach to predict whether a person with type 2 diabetes will develop kidney disease, a frequent and dangerous ...
May 15, 2023
0
41
Research involving pediatricians from the Hospital General de Valencia has shown that the children of women who were obese or had diabetes during pregnancy developed certain epigenetic alterations that predisposed them to ...
May 12, 2023
0
2
GLP1 receptor agonists—a class of diabetes medications—are associated with fewer major adverse cardiovascular events than another type of diabetes drug (DPP4 inhibitors) in older veterans with no prior heart disease. ...
May 8, 2023
0
43
Diabetes is a known risk factor for developing cancer, but could it also predict how cancer patients respond to treatment?
May 4, 2023
0
3